5Mir O,Alexandre J,Tran A,et al.Relati onship between GSTP1 Ilel05Val polymorphism and docetaxel-induced peripheral neuropathy:clinical evidence of a role of oxidative stress in taxane toxicity[J].Ann Oncol,2009,20(4):736-740.
6Cavaletti G,Alberti P,Marmiroli P.Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics[J].Lancet Oncol,2011,12(12):1151-1161.
7Sissung TM,Baum CE,Deeken J,et al.ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel[J].Clin Cancer Res,2008,14(14):4543-4549.
8Leskel S,Jara C,Leandro-Garcia L,et al.Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity[J].Pharmacogenomics J,2010,11 (2):121-129.
9Rizzo R,Spaggiari F,Indelli M,et al.Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients[J].Breast Cancer Res Treat,2010,124(2):593-598.
10Schneider B,Li L,Miller K,et al.Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103[J].J Clin Oncol,2011,29(15 suppl):1000.
